No bleeding episodes were seen over three years for 64% of hemophilia A patients given giroctocogene fitelparvovec in a trial ...

The two-part Phase 1/2 trial — dubbed BeCoMe-9 (NCT06611436) — was designed to assess the safety and clinical activity of a ...

To protect her ankles from internal bleeding and pain, columnist G Shellye Horowitz opts for sensible shoes lined with custom ...

Bone mineral density is decreased in 63.1% of people with hemophilia, according to a recent study from Germany.

Men in Japan with hemophilia and HIV had a 23 times higher risk of liver cancer and a 9.4 times rise in thyroid cancer ...

With travel scholarships available for the 2025 Coalition for Hemophilia B Symposium, columnist Jennifer Lynne encourages readers to attend.

Columnist Joe MacDonald reflects on moments of joy from one of his oldest son's first Christmases. It was a welcome respite from hemophilia.

Columnist Jennifer Lynne pens a wish list to Santa, full of her hopes and dreams for the future of those living with bleeding disorders.

Columnist Joe MacDonald's son may be living with a disability due to lingering complications of hemophilia, but it won't determine his path.